IP Library Granted Patent US 9,637,721
Granted Patent B2
US 9,637,721 · App. 14/577,414 · Granted May 2, 2017

Media for cell culture

Inventors: Adam Elhofy (Chicago, IL); Allan Weber (Robbinsville, NJ)
Assignee: BIO-ESS LABORATORIES, LLC.
C12N5/0037C12N2500/24C12N2500/35C12N2500/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,637,721
App. No.
14/577,414
Granted
May 2, 2017
Kind
B2
Abstract

The present disclosure relates, in general, to a media, e.g., a serum replacement, media supplement, complete media or cryopreservation media, comprising a base physiological buffer and liposomes comprising cholesterol, phosphatidylcholine and fatty acids. It is contemplated that media provides advantages to improve cell growth in culture compared to cells cultured not using the serum replacement described herein.

Claims (8)

1. A medium for use with cells in suspension or in adherent culture, the medium comprising a base physiological buffer liquid mix and liposomes comprising cholesterol, phosphatidylcholine, and fatty acids, wherein the liposome is in an amount such that the final concentration of cholesterol in the liposome is from 10 to 200 mg/L, and wherein the final concentration of phosphatidylcholine in the liposome is from 50 mg/L to 1 g/L.

2. The medium of claim 1 , wherein the liposome comprises one or more fatty acids selected from the group consisting of linolenic acid, linoleic acid, myristic acid and oleic acid.

3. The medium of claim 1 , wherein the liposome further comprises ethanol amine and polysorbate.

4. The medium of claim 1 , wherein the base physiological buffer liquid mix comprises one or more supplement selected from the group consisting of an organic salt, inorganic salt, buffer, iron source or iron transporter, glycerol, amino acid, vitamin, sugar, antioxidant and trace element.

5. The medium of claim 1 , wherein the medium is a serum replacement, complete medium, medium supplement, or cryopreservation medium.

6. The serum replacement, complete medium, medium supplement, or cryopreservation medium of claim 5 , wherein the liposome is a nanoparticle.

7. A method of culturing cells comprising culturing cells in a medium of claim 1 .

8. The method of claim 7 , wherein the cell is selected from the group consisting of pluripotent stem cells, embryonic stem cells, bone marrow stromal cells, hematopoietic progenitor cells, lymphoid stem cells, myeloid stein cells, T cells, B cells, macrophages, hepatic cells, pancreatic cells, carcinoma cells and cell lines.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Jan 31, 2017
From: ESSENTIAL PHARMACEUTICALS, LLC
To: BIO-ESS LABORATORIES, LLC
Reel/Frame 041128/0634 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2017
From: ELHOFY, ADAM; WEBER, ALLAN
To: ESSENTIAL PHARMACEUTICALS, LLC
Reel/Frame 041065/0786 →
Continuity (2)
Provisional Application 61918833 · Dec 20, 2013
Related Publication 20150175956A1 · Jun 25, 2015